ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01745302
Recruitment Status : Enrolling by invitation
First Posted : December 10, 2012
Last Update Posted : July 13, 2016
Sponsor:
Collaborator:
Shanghai Chest Hospital
Information provided by (Responsible Party):
Ling Xu, Shanghai University of Traditional Chinese Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2016